[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Radiotherapy Market, 2012 to 2023

January 2018 | 193 pages | ID: R1505FFB9E6EN
Precision Business Insights (PBI)

US$ 4,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Radiotherapy market: Radiotherapy is also called as radiation therapy. Radiotherapy refers to using radiation such as electronic beams, protons, X-rays and others to treat the diseases. Radiation therapy used to kill the cancer cells. When body tissue exposed to radiation, cancer cells and normal cells both are affected but normal cells usually repair themselves whereas cancer cells cannot. Radiotherapy used in many ways such as curative radiotherapy (to cure cancer completely), chemo radiation (make other treatment more effective, for instance, radiotherapy often used along with chemotherapy), Adjuvant therapy (reduce risk of cancer after surgery) and palliative therapy (relieving symptoms of cancer). Radiotherapy can be given by using external devices, implants or radiotherapy injections based on the condition.

Global Market Outline: Radiotherapy Market

Radiotherapy market mainly is driven by increase in incidence and prevalence of cancer and rise in demand for the non-invasive therapies of cancer globally. According to World Health Organization (WHO), cancer is estimated to be one of the leading cause of deaths worldwide. In 2012, 14 Mn new cancer cases are diagnosed and new cancer cases will rise to 22 Mn within next two decades. In addition, technological advances in radiotherapy such as image guided radiation therapy (IMRT) and increase in adaptation of radiotherapy to treat cancer are expected to bolster the radiotherapy market over the forecast period. Furthermore, developing healthcare infrastructure and favourable government policies are expected to boost the market. However, high cost of equipment, treatment and side effects are restraining the radiotherapy market globally during the forecast period.

Global radiotherapy market is segmented based on device type and end-user

Based on device type, radiotherapy market is segmented into

External Radiotherapy
Internal Radiotherapy (Brachytherapy)
Systemic Radiotherapy

Based on end-user, radiotherapy market is segmented into

Hospitals
Diagnostic Centres
Ambulatory surgical centres
Radiotherapy Centres

Market players are focus on product innovations and product launches to increase their market share and to sustain their positions in the radiotherapy market. In June 2017, Varian medical System received clearance from U.S. FDA to launch its new device, Halyon System to treat cancer. Furthermore, companies adopting strategies such as mergers and acquisitions to strengthen their market in radiotherapy segment. For instance in 2011, Elekta AB acquired Nucletron- a leader in brachytherapy treatment planning and delivery- to strengthen their radiotherapy product portfolio. Academic and research institutions are also contributing to radiation therapy development by collaborating with market players. For instance, in March 2016, Weill Cornell Medicine, a biomedical research unit and medical school formed a strategic alliance with the Janssen Biotech, Inc. (Johnson & Johnson Services Inc.,) to study the preclinical efficiency of combining external radiotherapy with Janssen’s immune oncology drugs.

Geographically radiotherapy market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America radiotherapy market expected to grow at notable rates owing to technological advancements, well-established healthcare infrastructure and favourable government policies. In addition growing prevalence of cancer expected to boost the radiotherapy market in this region. According to National Cancer Institute (NIH) estimated that in 2016, 1,685,210 new cases of cancer will be diagnosed in the united states. A number of new cases of cancer is 454.8 per 100,000 men and woman per year. Europe radiotherapy market expected to grow at significant rate owing to increase in cancer incidents and rise in adaptation of radiotherapy in the treatment of cancer. Asia Pacific radiotherapy market expected to grow at higher rate owing to increase in cancer cases, developing healthcare infrastructure and rising disposable income. According to WHO, more than 60% of new cancer cases occur in Asia, Africa and Central and South America.

Some of the players in radiotherapy market are Varian Medical Systems, Inc. (U.S.), Ion Beam Applications (IBA) (Belgium), Accuray Incorporated (U.S.), Nordion, Inc. (Canada), Elekta AB (Sweden), Isoray Medical, Inc. (U.S.), C. R. Bard, Inc. (U.S.), ViewRay, Inc. (U.S.), RaySearch Laboratories (Sweden), Mitsubishi Electric Corporation (Japan), iCad Inc (Xoft) (U.S.), and Mevion Medical Systems, Inc. (U.S.) to name a few.

In February 2017, US Food and Drug Administration (FDA) approved ViewRay’s MRIdian Linac System, the first device that Combines MRI guidance with linear accelerator radiation
1. EXECUTIVE SUMMARY

2. GLOBAL RADIOTHERAPY MARKET INTRODUCTION

2.1. Global Radiotherapy Market – Taxonomy
2.2. Global Radiotherapy Market –Definitions
  2.2.1. Device Type
  2.2.2. End-User

3. GLOBAL RADIOTHERAPY MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Radiotherapy Market Dynamics – Factors Impact Analysis
3.6. Global Radiotherapy Market – Regulations
  3.6.1. U.S.
  3.6.2. Europe

4. GLOBAL RADIOTHERAPY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. GLOBAL RADIOTHERAPY MARKET, BY DEVICE TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. External Radiotherapy
  5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.1.3. Market Opportunity Analysis
5.2. Internal Radiotherapy (Brachytherapy)
  5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis
5.3. Systemic Radiotherapy
  5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.3.3. Market Opportunity Analysis

6. GLOBAL RADIOTHERAPY MARKET FORECAST, BY END-USER, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Hospitals
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. Diagnostic Centres
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis
6.3. Ambulatory surgical centres
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.3.3. Market Opportunity Analysis
6.4. Radiotherapy Centres
  6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.4.3. Market Opportunity Analysis

7. GLOBAL RADIOTHERAPY MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. North America
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Europe
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis
7.4. Latin America
  7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
  7.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.5.3. Market Opportunity Analysis
7.6. Global Radiotherapy Market - Opportunity Analysis Index, By Device Type, By End-User, and Region, 2017 – 2023

8. NORTH AMERICA RADIOTHERAPY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. Device Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  8.1.1. External Radiotherapy
  8.1.2. Internal Radiotherapy (Brachytherapy)
  8.1.3. Systemic Radiotherapy
8.2. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  8.2.1. Hospitals
  8.2.2. Diagnostic Centres
  8.2.3. Ambulatory surgical centres
  8.2.4. Radiotherapy Centres
8.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  8.3.1. U.S.
  8.3.2. Canada
8.4. North America Radiotherapy Market - Opportunity Analysis Index, By Device Type, By End-User, and Country, 2017 – 2023
8.5. North America Radiotherapy Market Dynamics – Trends

9. EUROPE RADIOTHERAPY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

9.1. Device Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  9.1.1. External Radiotherapy
  9.1.2. Internal Radiotherapy (Brachytherapy)
  9.1.3. Systemic Radiotherapy
9.2. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  9.2.1. Hospitals
  9.2.2. Diagnostic Centres
  9.2.3. Ambulatory surgical centres
  9.2.4. Radiotherapy Centres
9.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  9.3.1. Germany
  9.3.2. UK
  9.3.3. France
  9.3.4. Spain
  9.3.5. Italy
  9.3.6. Russia
  9.3.7. Poland
  9.3.8. Rest of Europe
9.4. Europe Radiotherapy Market - Opportunity Analysis Index, By Device Type, By End-User, and Country, 2017 – 2023
9.5. Europe Radiotherapy Market Dynamics – Trends

10. ASIA-PACIFIC RADIOTHERAPY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

10.1. Device Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  10.1.1. External Radiotherapy
  10.1.2. Internal Radiotherapy (Brachytherapy)
  10.1.3. Systemic Radiotherapy
10.2. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  10.2.1. Hospitals
  10.2.2. Diagnostic Centres
  10.2.3. Ambulatory surgical centres
  10.2.4. Radiotherapy Centres
10.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
  10.3.1. Japan
  10.3.2. China
  10.3.3. India
  10.3.4. ASEAN
  10.3.5. Australia & New Zealand
  10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Radiotherapy Market - Opportunity Analysis Index, By Device Type, By End-User, and Country, 2017 – 2023
10.5. Europe Radiotherapy Market Dynamics – Trends

11. LATIN AMERICA RADIOTHERAPY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

11.1. Device Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  11.1.1. External Radiotherapy
  11.1.2. Internal Radiotherapy (Brachytherapy)
  11.1.3. Systemic Radiotherapy
11.2. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  11.2.1. Hospitals
  11.2.2. Diagnostic Centres
  11.2.3. Ambulatory surgical centres
  11.2.4. Radiotherapy Centres
11.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  11.3.1. Brazil
  11.3.2. Mexico
  11.3.3. Argentina
  11.3.4. Venezuela
  11.3.5. Rest of Latin America
11.4. Latin America Radiotherapy Market - Opportunity Analysis Index, By Device Type, By End-User, and Country, 2017 – 2023
11.5. Latin America Radiotherapy Market Dynamics – Trends

12. MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

12.1. Device Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  12.1.1. External Radiotherapy
  12.1.2. Internal Radiotherapy (Brachytherapy)
  12.1.3. Systemic Radiotherapy
12.2. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  12.2.1. Hospitals
  12.2.2. Diagnostic Centres
  12.2.3. Ambulatory surgical centres
  12.2.4. Radiotherapy Centres
12.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  12.3.1. Gulf Cooperation Council (GCC) Countries
  12.3.2. Israel
  12.3.3. South Africa
  12.3.4. Rest of MEA
12.4. MEA Radiotherapy Market - Opportunity Analysis Index, By Device Type, By End-User, and Country, 2017 – 2023
12.5. MEA Radiotherapy Market Dynamics – Trends

13. COMPETITION LANDSCAPE

13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Disease Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  13.2.1. Ion Beam Applications (IBA) (Belgium)
  13.2.2. Accuray Incorporated (U.S.)
  13.2.3. Nordion, Inc. (Canada)
  13.2.4. Elekta AB (Sweden)
  13.2.5. Isoray Medical, Inc. (U.S.)
  13.2.6. C. R. Bard, Inc. (U.S.)
  13.2.7. ViewRay, Inc. (U.S.)
  13.2.8. RaySearch Laboratories (Sweden)
  13.2.9. Mitsubishi Electric Corporation (Japan)
  13.2.10. iCad Inc (Xoft) (U.S.)
  13.2.11. Mevion Medical Systems, Inc. (U.S.)

14. RESEARCH METHODOLOGY

15. KEY ASSUMPTIONS AND ACRONYMS


More Publications